A pharmacological network for lifespan extension in Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary: One goal of aging research is to find drugs that delay the onset of age‐associated disease. Studies in invertebrates, particularly C aenorhabditis elegans, have uncovered numerous genes involved in aging, many conserved in mammals. However, which of these encode proteins suitable for drug targeting is unknown. To investigate this question, we screened a library of compounds with known mammalian pharmacology for compounds that increase C. elegans lifespan. We identified 60 compounds that increase longevity in C. elegans, 33 of which also increased resistance to oxidative stress. Many of these compounds are drugs approved for human use. Enhanced resistance to oxidative stress was associated primarily with compounds that target receptors for biogenic amines, such as dopamine or serotonin. A pharmacological network constructed with these data reveal that lifespan extension and increased stress resistance cluster together in a few pharmacological classes, most involved in intercellular signaling. These studies identify compounds that can now be explored for beneficial effects on aging in mammals, as well as tools that can be used to further investigate the mechanisms underlying aging in C. elegans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · cited 2×
“Standard quality control measures for high-throughput assays, such as the Z’ factor (Zhang et al., 1999), are inadequate for lifespan screens because survival data are not normally distributed (Fig.”
BackgroundRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 5×
“…Petrascheck et al., 2007; McColl et al., 2008; Srivastava et al., 2008; Pietsch et al., 2009; Onken & Driscoll, 2010; Alavez et al., 2011) and also confirmed in mice by the finding that lifespan can be increased by rapamycin, an immunosuppressant that blocks TOR activity (Harrison et al., 2009).”
BackgroundInfluentialIGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 2×
“…California, USA 3The Scripps Translational Science Institute, Scripps Health, La Jolla, California, USA 4Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA 5Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, California, USA”
BackgroundmTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676 · cited 2×
“…onset, or improve the outcome, of certain age-related diseases, such as cancer or neurodegenerative disease in C. elegans and mouse models of these diseases (Hursting et al., 1994; Pinkston et al., 2006; Raffaghello et al., 2008; Cohen et al., 2009; Rangaraju et al., 2009; Johnson et al., 2013).”
BackgroundMitonuclear protein imbalance as a conserved longevity mechanism
Houtkooper, R. H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., Williams, R. W., & Auwerx, J. (2013) · Nature · doi:10.1038/nature12188 · Cited by 1,035 · cited 6×
“to these analyses, also belonged to the selected hits (Houtkooper et al., 2013).”
BackgroundInfluentialMetformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · cited 2×
“elegans with dead, or nonproliferating bacteria can increase lifespan (Gems & Riddle, 2000; Garigan et al., 2002; Cabreiro et al., 2013).”
BackgroundOnken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 1×
“…al., 2002; Evason et al., 2005; Wilson et al., 2006; Petrascheck et al., 2007; McColl et al., 2008; Srivastava et al., 2008; Pietsch et al., 2009; Onken & Driscoll, 2010; Alavez et al., 2011) and also confirmed in mice by the finding that lifespan can be increased by rapamycin, an…”
BackgroundTOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. D., Neumann-Haefelin, E., Sabatini, D. M., & Blackwell, T. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.007 · Cited by 648
Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., & Longo, V. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708100105 · Cited by 587 · cited 2×
“…onset, or improve the outcome, of certain age-related diseases, such as cancer or neurodegenerative disease in C. elegans and mouse models of these diseases (Hursting et al., 1994; Pinkston et al., 2006; Raffaghello et al., 2008; Cohen et al., 2009; Rangaraju et al., 2009; Johnson et al., 2013).”
BackgroundDeletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans
Van Raamsdonk, J. M., & Hekimi, S. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000361 · Cited by 511 · cited 2×
“While increased oxidative stress resistance alone is unlikely to be sufficient to increase longevity, it may be associated with an array of changes that together increase lifespan in certain settings (Gems & Doonan, 2009; Van Raamsdonk & Hekimi, 2009; Yang & Hekimi, 2010; Shore et al., 2012).”
BackgroundResultReduced IGF-1 signaling delays age-associated proteotoxicity in mice
Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.014 · Cited by 488
Dietary deprivation extends lifespan in Caenorhabditis elegans
Lee, G. D., Wilson, M. A., Zhu, M., Wolkow, C. A., De Cabo, R., Ingram, D. K., & Zou, S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00241.x · Cited by 307 · cited 3×
“Decreased insulin/IGF signaling and some DR regimens also increase both lifespan and oxidative stress resistance in C. elegans (Honda & Honda, 1999; Houthoofd et al., 2002; Lee et al., 2006).”
BackgroundMutations That Increase the Life Span of C. elegans Inhibit Tumor Growth
Pinkston, J. M., Garigan, D., Hansen, M., & Kenyon, C. (2006) · Science · doi:10.1126/science.1121908 · Cited by 242
Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans
McColl, G., Killilea, D. W., Hubbard, A. E., Vantipalli, M. C., Melov, S., & Lithgow, G. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705028200 · Cited by 202 · cited 2×
“…lifespan has now been amply demonstrated in invertebrates (Kang et al., 2002; Evason et al., 2005; Wilson et al., 2006; Petrascheck et al., 2007; McColl et al., 2008; Srivastava et al., 2008; Pietsch et al., 2009; Onken & Driscoll, 2010; Alavez et al., 2011) and also confirmed in mice by the…”
Background
Cited by
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan
Silvestrini, M. J., Johnson, J. R., Kumar, A. V., Thakurta, T. G., Blais, K., Neill, Z. A., Marion, S. W., St. Amand, V., Reenan, R. A., & Lapierre, L. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.063 · Cited by 101
Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
Strong, R., Miller, R. A., Bogue, M., Fernandez, E., Javors, M. A., Libert, S., Marinez, P. A., Murphy, M. P., Musi, N., Nelson, J. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13269 · Cited by 92
Self-citationYouthful and age-related matreotypes predict drugs promoting longevity
Statzer, C., Jongsma, E., Liu, S. X., Dakhovnik, A., Wandrey, F., Mozharovskyi, P., Zülli, F., & Ewald, C. Y. (2021) · Aging Cell · doi:10.1111/acel.13441 · Cited by 45
The landscape of longevity across phylogeny
Podolskiy, D. I., Avanesov, A., Tyshkovskiy, A., Porter, E., Petrascheck, M., Kaeberlein, M., & Gladyshev, V. N. (2020) · doi:10.1101/2020.03.17.995993 · Cited by 4
Self-citation
Metadata
- Authors
- Ye, X., Linton, J. M., Schork, N. J., Buck, L. B., & Petrascheck, M.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2013-11-13
- Volume
- 13
- Issue
- 2
- Pages
- 206-215
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W2108574037
- Cited by
- 131
- References
- 14
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.